MA
Mark A Goldsmith
DELAYED 1 MONTH
Director, President and Chief Executive Officer
Revolution Medicines, Inc.
Filings
1
Companies
1
Latest
Mar 1, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
63
RVMD36% OUT
Revolution Medicines, Inc.
Mark A Goldsmith
Director, President and Chief Executive Officer
Sale
$3.6M
36,000 sh
Mar 4 2:09 AM
Mar 2, 2026
—
Revolution Medicines, Inc.
Mark A Goldsmith
Director, President and Chief Executive Officer
Option Exercise
$122.7K
30,000 sh
Mar 4 2:09 AM
Mar 2, 2026